A Comparison Study of Patient Controlled Epidural Analgesia (PCEA) With and Without Basal Infusion Using Ropivacaine 0,15% and Fentanyl μg/ml for Pain Relief in Labor, Assessment of Efficacy and Maternal Satisfaction.
1 other identifier
interventional
65
1 country
1
Brief Summary
This is a prospective, randomized, double blind study, in which a comparison of patient controlled epidural analgesia (PCEA) of continuous background infusion with demand dose and demand only, using ropivacaine 0,15% and fentanyl 2μg/ml for pain relief in labor, is being investigated. The purpose of the study is the assessment of the efficacy of labor analgesia and maternal satisfaction. Written informed consent is obtained by all parturients. Non invasive monitor of blood pressure, heart rate, SpO2, ECG for the patient and a continuous monitoring of the fetal heart rate is being placed. The participants are randomized in two groups, both receiving the same drug (ropivacaine 0,15% and fentanyl 2μg/ml). Group 0 receives demand dose of 5 ml with lockout of 10 minutes. Group 1 receives background infusion of 5 ml/h and demand dose of 5 ml with lockout 10 minutes. All parturients have to be instructed to self administration of epidural bolus dose when they experience mild to moderate pain. Both parturient and anesthetist who conducts the study and treat breakthrough pain, are blind to group assignment. After the last suture, total volume of epidural infusions of PCEA, total infused drug of PCEA pump, number of delivered PCEA boluses and manual rescue doses are being calculated. Time of delivery, mode of delivery, Apgar scores, and overall maternal satisfaction scores, neonate pH and Hct of the patient (ABGS), as well as possible need of newborn cardiopulmonary resuscitation are also recorded.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2014
CompletedFirst Submitted
Initial submission to the registry
March 5, 2014
CompletedFirst Posted
Study publicly available on registry
March 12, 2014
CompletedApril 8, 2014
April 1, 2014
1.7 years
March 5, 2014
April 6, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The primary outcome is the total volume of epidural local anaesthetic (LA) administrated during labor.
Approximately 30 min (time of preloading) before the initiation of the epidural technique to 24 h after removal of the epidural catheter.
Study Arms (2)
PCEA of continuous background infusion with demand dose
ACTIVE COMPARATORPCEA with background infusion of 5 ml/h and demand dose of 5 ml with lockout 10 minutes, using ropivacaine 0,15% and fentanyl 2μg/ml.
PCEA with demand dose only
ACTIVE COMPARATORPCEA with demand dose of 5 ml with lockout 10 minutes, using ropivacaine 0,15% and fentanyl 2μg/ml.
Interventions
Eligibility Criteria
You may qualify if:
- Age between 18 and 40 years,
- ASA status I or II,
- Primigravida or secundigravida
- Gestational age \> 38 weeks,
- Cervical dilatation ≥ 4 cm,
- Request for epidural labor analgesia
You may not qualify if:
- Patients refusal to participate to the study
- History of clinical important cardiovascular, pulmonary, hepatic, neurological, psychiatric, metabolic or kidney disease
- Allergy to amino amide class of local anesthetics
- Contraindications to epidural analgesia
- Drug addiction or addiction to alcohol
- Administration of opioids in the last 3 hours before the initiation of labor epidural analgesia
- Use of chronic pain medications
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
2nd Department of Anesthesiology, Attikon University Hospital
Athens, Attica, 12462, Greece
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- MD, PhD
Study Record Dates
First Submitted
March 5, 2014
First Posted
March 12, 2014
Study Start
June 1, 2012
Primary Completion
February 1, 2014
Last Updated
April 8, 2014
Record last verified: 2014-04